IFT20
gene geneOn this page
Summary
IFT20 (intraflagellar transport 20, HGNC:30989) is a protein-coding gene on chromosome 17q11.2, encoding Intraflagellar transport protein 20 homolog (Q8IY31). Part of intraflagellar transport (IFT) particles involved in ciliary process assembly.
This gene encodes a intraflagellar transport protein important for intracellular transport. The encoded protein forms part of a complex involved in trafficking of proteins from the Golgi body, including recycling of immune signalling components (Finetti et al., PubMed: 19855387). This gene is part of a complex set of sense-antisense loci that may be co-regulated. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. A pseudogene of this gene is located on the long arm of chromosome 14.
Source: NCBI Gene 90410 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 30 total
- MANE Select transcript:
NM_001267776
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30989 |
| Approved symbol | IFT20 |
| Name | intraflagellar transport 20 |
| Location | 17q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000109083 |
| Ensembl biotype | protein_coding |
| OMIM | 614394 |
| Entrez | 90410 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 15 protein_coding, 6 retained_intron
ENST00000322326, ENST00000357896, ENST00000395418, ENST00000577498, ENST00000578009, ENST00000578122, ENST00000578547, ENST00000578985, ENST00000579419, ENST00000580357, ENST00000580991, ENST00000582797, ENST00000583796, ENST00000585089, ENST00000585313, ENST00000588477, ENST00000900357, ENST00000900358, ENST00000900359, ENST00000900360, ENST00000918609
RefSeq mRNA: 6 — MANE Select: NM_001267776
NM_001267774, NM_001267775, NM_001267776, NM_001267777, NM_001267778, NM_174887
CCDS: CCDS32593, CCDS58533, CCDS58534, CCDS58535, CCDS74017
Canonical transcript exons
ENST00000395418 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000705760 | 28330443 | 28330528 |
| ENSE00002686368 | 28335340 | 28335472 |
| ENSE00003492454 | 28329173 | 28329276 |
| ENSE00003526349 | 28331859 | 28331987 |
| ENSE00003900438 | 28328326 | 28328733 |
Expression profiles
Bgee: expression breadth ubiquitous, 294 present calls, max score 98.00.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 42.5507 / max 922.2382, expressed in 1821 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164982 | 38.3594 | 1820 |
| 164981 | 4.1751 | 1480 |
| 164980 | 0.0162 | 5 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 98.00 | gold quality |
| tibia | UBERON:0000979 | 97.82 | gold quality |
| parotid gland | UBERON:0001831 | 97.36 | gold quality |
| pituitary gland | UBERON:0000007 | 97.04 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.94 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.92 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.85 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.78 | gold quality |
| bronchial epithelial cell | CL:0002328 | 96.75 | gold quality |
| jejunal mucosa | UBERON:0000399 | 96.44 | gold quality |
| cerebellum | UBERON:0002037 | 96.28 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 96.23 | gold quality |
| bronchus | UBERON:0002185 | 96.16 | gold quality |
| periodontal ligament | UBERON:0008266 | 95.96 | gold quality |
| cardia of stomach | UBERON:0001162 | 95.85 | gold quality |
| pancreas | UBERON:0001264 | 95.68 | gold quality |
| monocyte | CL:0000576 | 95.47 | gold quality |
| left testis | UBERON:0004533 | 95.45 | gold quality |
| mononuclear cell | CL:0000842 | 95.43 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 95.38 | gold quality |
| seminal vesicle | UBERON:0000998 | 95.31 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 95.30 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 95.21 | gold quality |
| pylorus | UBERON:0001166 | 95.08 | gold quality |
| right testis | UBERON:0004534 | 95.08 | gold quality |
| leukocyte | CL:0000738 | 95.07 | gold quality |
| duodenum | UBERON:0002114 | 94.93 | gold quality |
| right uterine tube | UBERON:0001302 | 94.86 | gold quality |
| body of stomach | UBERON:0001161 | 94.79 | gold quality |
| testis | UBERON:0000473 | 94.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ETS1, MXI1
miRNA regulators (miRDB)
23 targeting IFT20, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-6853-3P | 99.36 | 70.79 | 1558 |
| HSA-MIR-548V | 99.29 | 69.47 | 1157 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-361-3P | 99.19 | 66.45 | 1381 |
| HSA-MIR-6876-3P | 98.97 | 65.69 | 765 |
| HSA-MIR-626 | 98.89 | 66.21 | 762 |
| HSA-MIR-4297 | 98.77 | 66.95 | 2013 |
| HSA-MIR-5581-5P | 97.91 | 66.50 | 965 |
Literature-anchored findings (GeneRIF, showing 9)
- Data report the molecular cloning and characterization of a novel human cDNA encoding a putative protein of 158 amino acid residues which shares high homology to Mus musculus intraflagellar transport protein mIFT20. (PMID:14672413)
- This work suggests that IFT20 functions in the delivery of ciliary membrane proteins from the Golgi complex to the cilium. (PMID:16775004)
- IFT20 is required for the delivery of the intracellular pool of LAT to the immune synapse in naive primary T lymphocytes. (PMID:26715756)
- the traffic-related role of an IFT20 complex that includes components of the intracellular trafficking machinery in immune synapse assembly, is reported. (PMID:28154159)
- Authors showed that in chondrocytes from human (ACH, TD) and mouse Fgfr3Y367C/+ cartilage, the constitutively active FGFR3 perturbed PC length and the sorting and trafficking of intraflagellar transport (IFT) 20 to the PC. (PMID:29040558)
- intraflagellar transport protein 20 (IFT20) interacts with E3 ubiquitin ligases c-Cbl and Cbl-b and is required for Cbl-mediated ubiquitination and internalization of PDGFRalpha for feedback inhibition of receptor signaling. (PMID:29237719)
- These results indicate that IFT20 plays an important role in collective invasion of CRC cells by regulating organization of Golgi-associated, stabilized microtubules and Golgi polarity in leader cells. (PMID:30742741)
- The intraflagellar transport protein IFT20 controls lysosome biogenesis by regulating the post-Golgi transport of acid hydrolases. (PMID:31142807)
- Associations of IFT20 and GM130 protein expressions with clinicopathological features and survival of patients with lung adenocarcinoma. (PMID:35869490)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ift20 | ENSDARG00000040556 |
| mus_musculus | Ift20 | ENSMUSG00000001105 |
| rattus_norvegicus | Ift20 | ENSRNOG00000008891 |
| drosophila_melanogaster | IFT20 | FBGN0050441 |
| caenorhabditis_elegans | ift-20 | WBGENE00022465 |
Protein
Protein identifiers
Intraflagellar transport protein 20 homolog — Q8IY31 (reviewed: Q8IY31)
All UniProt accessions (6): Q8IY31, A0A087X2B4, J3KRU2, J3QR43, J3QRC6, J3QRH2
UniProt curated annotations — full annotation on UniProt →
Function. Part of intraflagellar transport (IFT) particles involved in ciliary process assembly. May play a role in the trafficking of ciliary membrane proteins from the Golgi complex to the cilium. Regulates the platelet-derived growth factor receptor-alpha (PDGFRA) signaling pathway. Required for protein stability of E3 ubiquitin ligases CBL and CBLB that mediate ubiquitination and internalization of PDGFRA for proper feedback inhibition of PDGFRA signaling. Essential for male fertility. Plays an important role in spermatogenesis, particularly spermiogenesis, when germ cells form flagella. May play a role in the transport of flagellar proteins ODF2 and SPAG16 to build sperm flagella and in the removal of redundant sperm cytoplasm. Also involved in autophagy since it is required for trafficking of ATG16L and the expansion of the autophagic compartment.
Subunit / interactions. Component of the IFT complex B, at least composed of IFT20, IFT22, IFT25, IFT27, IFT46, IFT52, TRAF3IP1/IFT54, IFT57, IFT74, IFT80, IFT81, and IFT88. Interacts directly with IFT57 and KIF3B/Kinesin II subunit. Interacts with IFT88. Interacts with CEP83. Interacts with SPEF2 (via C-terminus). Interacts with CBL and CBLB. Interacts with TRIP11. Interacts with TTC21A. Interacts with SPATA1. Interacts with USH1G. Interacts with CCDC146. Interacts with CEP78; regulating IFT20 stability and localization.
Subcellular location. Golgi apparatus. cis-Golgi network. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriole. Cilium basal body. Cell projection. Cilium. Cytoplasmic vesicle. Secretory vesicle. Acrosome.
Tissue specificity. Expressed in almost all tissues.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IY31-1 | 1 | yes |
| Q8IY31-2 | 2 | |
| Q8IY31-3 | 3 | |
| Q8IY31-4 | 4 |
RefSeq proteins (6): NP_001254703, NP_001254704, NP_001254705, NP_001254706, NP_001254707, NP_777547 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028172 | FT20 | Family |
Pfam: PF14931
UniProt features (6 total): splice variant 3, chain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IY31-F1 | 94.51 | 0.82 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5620924 | Intraflagellar transport |
MSigDB gene sets: 262 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, ATF_B, GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY, GOBP_MUSCLE_TISSUE_DEVELOPMENT, GOBP_COGNITION, MYOGENIN_Q6, GOBP_BEHAVIOR, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, GOBP_VACUOLE_ORGANIZATION, GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY, GOCC_SECRETORY_GRANULE
GO Biological Process (28): establishment of planar polarity (GO:0001736), kidney development (GO:0001822), smoothened signaling pathway (GO:0007224), spermatogenesis (GO:0007283), visual learning (GO:0008542), protein localization to Golgi apparatus (GO:0034067), intraciliary anterograde transport (GO:0035720), photoreceptor cell outer segment organization (GO:0035845), opsin transport (GO:0036372), establishment of epithelial cell apical/basal polarity (GO:0045198), positive regulation of cilium assembly (GO:0045724), centrosome localization (GO:0051642), cardiac muscle cell differentiation (GO:0055007), inner ear receptor cell stereocilium organization (GO:0060122), cilium assembly (GO:0060271), regulation of canonical Wnt signaling pathway (GO:0060828), neural precursor cell proliferation (GO:0061351), protein localization to cilium (GO:0061512), protein transmembrane transport (GO:0071806), protein localization to plasma membrane (GO:0072659), cochlea development (GO:0090102), regulation of cilium assembly (GO:1902017), regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583), regulation of autophagosome assembly (GO:2000785), neurogenesis (GO:0022008), cell projection organization (GO:0030030), cell differentiation (GO:0030154), intraciliary transport (GO:0042073)
GO Molecular Function (3): opsin binding (GO:0002046), small GTPase binding (GO:0031267), protein binding (GO:0005515)
GO Cellular Component (27): Golgi membrane (GO:0000139), acrosomal vesicle (GO:0001669), photoreceptor outer segment (GO:0001750), manchette (GO:0002177), cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), cis-Golgi network (GO:0005801), centrosome (GO:0005813), centriole (GO:0005814), microvillus (GO:0005902), cilium (GO:0005929), intraciliary transport particle (GO:0030990), intraciliary transport particle A (GO:0030991), intraciliary transport particle B (GO:0030992), motile cilium (GO:0031514), photoreceptor connecting cilium (GO:0032391), stereocilium (GO:0032420), ciliary basal body (GO:0036064), neuron projection (GO:0043005), dendrite terminus (GO:0044292), ciliary tip (GO:0097542), ciliary base (GO:0097546), non-motile cilium (GO:0097730), kinociliary basal body (GO:1902636), cytoskeleton (GO:0005856), cytoplasmic vesicle (GO:0031410), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Assembly of the 9+0 primary cilium | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| microtubule organizing center | 3 |
| intraciliary transport particle | 3 |
| protein-containing complex | 3 |
| protein localization to organelle | 2 |
| protein transport | 2 |
| Golgi apparatus | 2 |
| photoreceptor cell cilium | 2 |
| intracellular membrane-bounded organelle | 2 |
| actin-based cell projection | 2 |
| plasma membrane bounded cell projection | 2 |
| cilium | 2 |
| morphogenesis of a polarized epithelium | 1 |
| establishment of tissue polarity | 1 |
| animal organ development | 1 |
| renal system development | 1 |
| cell surface receptor signaling pathway | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| visual behavior | 1 |
| associative learning | 1 |
| intraciliary transport | 1 |
| cellular component organization | 1 |
| photoreceptor cell development | 1 |
| polarized epithelial cell differentiation | 1 |
| establishment of apical/basal cell polarity | 1 |
| establishment or maintenance of epithelial cell apical/basal polarity | 1 |
| establishment of epithelial cell polarity | 1 |
| cilium assembly | 1 |
| positive regulation of plasma membrane bounded cell projection assembly | 1 |
| regulation of cilium assembly | 1 |
| positive regulation of organelle assembly | 1 |
| microtubule organizing center localization | 1 |
| cardiocyte differentiation | 1 |
| cardiac muscle tissue development | 1 |
| striated muscle cell differentiation | 1 |
| neuron projection development | 1 |
| inner ear receptor cell development | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
Protein interactions and networks
STRING
1382 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IFT20 | IFT57 | Q9NWB7 | 996 |
| IFT20 | IFT54 | Q8TDR0 | 995 |
| IFT20 | IFT80 | Q9P2H3 | 990 |
| IFT20 | IFT52 | Q9Y366 | 986 |
| IFT20 | IFT38 | Q96AJ1 | 981 |
| IFT20 | IFT172 | Q9UG01 | 979 |
| IFT20 | IFT88 | Q13099 | 967 |
| IFT20 | IFT27 | Q9BW83 | 966 |
| IFT20 | IFT46 | Q9NQC8 | 965 |
| IFT20 | TRIP11 | Q15643 | 959 |
| IFT20 | IFT25 | Q9Y547 | 949 |
| IFT20 | IFT22 | Q9H7X7 | 945 |
| IFT20 | IFT74 | Q96LB3 | 939 |
| IFT20 | RAB8A | P24407 | 930 |
| IFT20 | IFT81 | Q8WYA0 | 884 |
IntAct
149 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED4 | MED19 | psi-mi:“MI:0914”(association) | 0.900 |
| IFT57 | CORO1A | psi-mi:“MI:0914”(association) | 0.790 |
| IFT70A | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| IFT70B | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| IFT20 | KXD1 | psi-mi:“MI:0915”(physical association) | 0.770 |
| KXD1 | IFT20 | psi-mi:“MI:0915”(physical association) | 0.770 |
| MED4 | IFT20 | psi-mi:“MI:0915”(physical association) | 0.740 |
| IFT20 | ABI2 | psi-mi:“MI:0915”(physical association) | 0.740 |
| EXOC7 | IFT20 | psi-mi:“MI:0915”(physical association) | 0.740 |
| IFT20 | EXOC7 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ABI2 | IFT20 | psi-mi:“MI:0915”(physical association) | 0.740 |
| IFT25 | IFT56 | psi-mi:“MI:0914”(association) | 0.690 |
| IFT27 | IFT56 | psi-mi:“MI:0914”(association) | 0.690 |
BioGRID (199): IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid), IFT20 (Two-hybrid)
ESM2 similar proteins: A1L3H4, A5A777, A6QR54, A6ZRZ4, A9ULR1, B2GV52, B3LNU5, C5E2E7, C7GUN6, C8ZGE4, P0CAP1, P33716, P35458, P48232, P57679, P70281, Q0IHJ3, Q32L59, Q3UIJ9, Q4R764, Q58CS6, Q5EB94, Q5I0J4, Q5RA87, Q5XIC3, Q5ZK77, Q60547, Q60595, Q61025, Q61806, Q63312, Q63520, Q640Z7, Q66I67, Q66KL7, Q6CQ94, Q6NPG7, Q6P205, Q750P7, Q80Y56
Diamond homologs: Q58CS6, Q61025, Q640Z7, Q66I67, Q66KL7, Q8IY31, Q8TA52, Q90WZ0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 71 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Intraflagellar transport | 14 | 62.3× | 5e-20 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| intraciliary anterograde transport | 13 | 198.8× | 3e-26 |
| intraciliary transport | 12 | 116.2× | 1e-20 |
| negative regulation of keratinocyte proliferation | 5 | 60.5× | 1e-06 |
| keratinocyte proliferation | 5 | 50.1× | 3e-06 |
| non-motile cilium assembly | 9 | 45.1× | 4e-11 |
| smoothened signaling pathway | 9 | 28.1× | 2e-09 |
| cilium assembly | 20 | 25.4× | 5e-21 |
| kidney development | 5 | 12.1× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1079 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:28330437:TCTTA:T | donor_loss | 1.0000 |
| 17:28330438:CTTAC:C | donor_loss | 1.0000 |
| 17:28330439:TTACC:T | donor_loss | 1.0000 |
| 17:28330440:TAC:T | donor_loss | 1.0000 |
| 17:28330441:A:AT | donor_loss | 1.0000 |
| 17:28330530:T:C | acceptor_gain | 1.0000 |
| 17:28330532:T:C | acceptor_gain | 1.0000 |
| 17:28330532:T:TC | acceptor_gain | 1.0000 |
| 17:28331850:AATAC:A | donor_loss | 1.0000 |
| 17:28331851:ATACT:A | donor_loss | 1.0000 |
| 17:28331852:TACT:T | donor_loss | 1.0000 |
| 17:28331853:AC:A | donor_loss | 1.0000 |
| 17:28331854:CTC:C | donor_loss | 1.0000 |
| 17:28331855:TCA:T | donor_loss | 1.0000 |
| 17:28331856:CA:C | donor_loss | 1.0000 |
| 17:28331857:A:AC | donor_gain | 1.0000 |
| 17:28331857:A:C | donor_loss | 1.0000 |
| 17:28331857:ACTGT:A | donor_gain | 1.0000 |
| 17:28331858:C:CC | donor_gain | 1.0000 |
| 17:28331858:CT:C | donor_gain | 1.0000 |
| 17:28331858:CTG:C | donor_gain | 1.0000 |
| 17:28331858:CTGT:C | donor_gain | 1.0000 |
| 17:28331858:CTGTC:C | donor_gain | 1.0000 |
| 17:28331882:T:TA | donor_gain | 1.0000 |
| 17:28331983:CATGG:C | acceptor_gain | 1.0000 |
| 17:28331984:ATGG:A | acceptor_gain | 1.0000 |
| 17:28331985:TGG:T | acceptor_gain | 1.0000 |
| 17:28331986:GG:G | acceptor_gain | 1.0000 |
| 17:28331986:GGC:G | acceptor_loss | 1.0000 |
| 17:28331987:GCT:G | acceptor_loss | 1.0000 |
AlphaMissense
880 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:28329179:A:G | L104P | 0.999 |
| 17:28329203:A:G | L96P | 0.999 |
| 17:28329212:A:G | L93P | 0.999 |
| 17:28329267:C:G | A75P | 0.999 |
| 17:28329269:C:T | G74D | 0.999 |
| 17:28329276:C:G | A72P | 0.999 |
| 17:28330472:C:G | A62P | 0.999 |
| 17:28328714:C:G | A113P | 0.998 |
| 17:28329207:C:G | A95P | 0.998 |
| 17:28329228:C:G | A88P | 0.998 |
| 17:28329249:A:G | S81P | 0.998 |
| 17:28329254:A:G | L79P | 0.998 |
| 17:28329259:G:C | N77K | 0.998 |
| 17:28329259:G:T | N77K | 0.998 |
| 17:28329263:C:G | R76P | 0.998 |
| 17:28329270:C:G | G74R | 0.998 |
| 17:28331888:A:G | L33P | 0.998 |
| 17:28328689:T:G | Q121P | 0.997 |
| 17:28329173:C:A | R106M | 0.997 |
| 17:28330474:A:G | L61P | 0.997 |
| 17:28331866:A:C | F40L | 0.997 |
| 17:28331866:A:T | F40L | 0.997 |
| 17:28331868:A:G | F40L | 0.997 |
| 17:28329173:C:G | R106T | 0.996 |
| 17:28329261:T:C | N77D | 0.996 |
| 17:28329275:G:T | A72D | 0.996 |
| 17:28330449:C:A | K69N | 0.996 |
| 17:28330449:C:G | K69N | 0.996 |
| 17:28330463:C:G | A65P | 0.996 |
| 17:28330515:A:C | F47L | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000285564 (17:28330504 A>G), RS1000572287 (17:28329987 G>A,C), RS1001100615 (17:28335720 C>G,T), RS1001151565 (17:28335513 C>A), RS1003006791 (17:28332400 C>T), RS1004174209 (17:28336017 T>A), RS1004290869 (17:28336305 C>G,T), RS1004469098 (17:28335144 A>C), RS1004521897 (17:28334850 G>A), RS1004754995 (17:28329644 G>T), RS1005352174 (17:28331363 C>T), RS1005817558 (17:28330977 G>A), RS1007461618 (17:28337400 C>G), RS1007509342 (17:28336834 C>G), RS1008819811 (17:28333668 T>C)
Disease associations
OMIM: gene MIM:614394 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002546_2 | Osteoprotegerin levels | 1.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, affects cotreatment, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| Valproic Acid | decreases methylation, increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| K 7174 | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Cisplatin | increases expression | 1 |
| Coumestrol | affects cotreatment, decreases expression | 1 |
| Demecolcine | increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Vanadates | decreases expression | 1 |
| Vincristine | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Isotretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.